Fearing potential tariffs from President Trump's announcement, some European drugmakers are increasing air shipments of ...

Altogether, allocating $4,000 into these four healthcare stocks on the TSX offers a balanced approach to investing in a sector that combines stability with growth potential. Each company presents ...

Clare Fitzell, recently elected as President of the Pharmaceutical Group of the European Union (PGEU) spoke with Euractiv about the Critical Medicines Act and its likely impact in Ireland, and the EU.

Japanese drug firm Chugai Pharmaceutical has established competitive advantages due to its alliance with majority shareholder Roche as well as its internal research and development engine. While ...

The Food and Drug Administration has found problems at an Indian factory that makes generic drugs for American patients, ...

Global investment firm KKR on Thursday divested a 5.8 per cent stake in JB Chemicals and Pharmaceuticals for Rs 1,460 crore ...

Addressing the calculation of patent term extensions (PTEs) under the Hatch-Waxman Act, the US Court of Appeals for the Federal Circuit affirmed ...

Concerns about potential pharma tariffs began before Trump took office after he repeatedly threatened a 25% tariff.

Not all corners of the market are moving in the same direction this year; 2025 has already delivered a few surprises for sector-focused investors ...

Deloitte urged pharma executives to “be bold” in a new report tracking the top 20 pharmaceutical companies’ R&D performance.

A copy of the Company’s poster will be available under the Scientific Presentations tab of the Tonix website at www.tonixpharma.com following the conference. Additional meeting information can be ...